Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from EZZ Life Science Holdings Ltd. ( (AU:EZZ) ).
EZZ Life Science Holdings Limited announced the results of its Annual General Meeting, where the re-election of Mr. Glenn Cross as a director was withdrawn following his decision not to stand for re-election. The board expressed gratitude for his contributions, and CEO Mark Qin will serve as interim Chair. The announcement reflects ongoing leadership changes and strategic adjustments within the company, potentially impacting its governance and operational strategies.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a life science company focused on enhancing quality of life and human health. The company invests in consumer health through e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China, and globally. EZZ is also expanding its market presence into the United States, a significant growth market.
Average Trading Volume: 75,840
Technical Sentiment Signal: Buy
Current Market Cap: A$109M
See more data about EZZ stock on TipRanks’ Stock Analysis page.